Protection from Herpes Simplex Virus (HSV)–2 Infection with Replication‐Defective HSV‐2 or Glycoprotein D2 Vaccines in HSV‐1–Seropositive and HSV‐1–Seronegative Guinea Pigs
Open Access
- 1 October 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 200 (7) , 1088-1095
Abstract
BackgroundA herpes simplex virus (HSV)–2 candidate vaccine consisting of glycoprotein D (gD2) in alum and monophosphoryl lipid A (MPL) reduced genitaKeywords
This publication has 20 references indexed in Scilit:
- Development and Use of a Type-Specific Antibody Avidity Test Based on Herpes Simplex Virus Type 2 Glycoprotein GSexually Transmitted Diseases, 2004
- The potential epidemiological impact of a genital herpes vaccine for womenSexually Transmitted Infections, 2004
- Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV‐1 or HSV‐2 Disease in Guinea PigsThe Journal of Infectious Diseases, 2003
- Glycoprotein-D–Adjuvant Vaccine to Prevent Genital HerpesNew England Journal of Medicine, 2002
- Construction, Phenotypic Analysis, and Immunogenicity of a UL5/UL29 Double Deletion Mutant of Herpes Simplex Virus 2Journal of Virology, 2000
- Immunization against genital herpes with a vaccine virus that has defects in productive and latent infectionProceedings of the National Academy of Sciences, 1999
- Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected MenJAMA, 1998
- The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.The Journal of Immunology, 1988
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Protection from Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein DScience, 1985